Wierenga Wendall

Wierenga Wendall is listed in filings as Director at Cytokinetics, Incorporated - Common Stock. This profile follows SEC Form 4 activity through Jul 16, 2025, including sale activity. Recent filings connect the profile to Cytokinetics, Incorporated - Common Stock (CYTK) and Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). The current snapshot covers public activity from Apr 16, 2025 to Jul 16, 2025. Reported amounts are shown as $6.2K to $326.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.